Objectives: Conventional Western treatments for obesity are associated with various adverse events (AEs). This study aimed to determine the treatment response and safety assessment of an integrative Korean medicine treatment (IKMT), consisting of herbal medicine (HM) and lifestyle modification (LM), for weight loss (WL) in people with obesity. Methods: The electronic medical records of outpatients from July 2021 to May 2023 at a Daeat Korean medicine clinic in Seoul were retrospectively reviewed. A total of 3161 patients were evaluated using bioelectrical impedance analysis (BIA) and blood pressure (BP) index. Moreover, the treatment response to IKMT in the 24 best cases (WL within BMI < 23 kg/m2) was evaluated using BIA and BP index, and the safety profile was determined by analyzing AEs. Results: The mean age was 38.2 ± 11.39 years, and the mean duration of treatment was 142.62 ± 104.92 days (approximately 20 weeks). The mean WL was 8.02 ± 6.67 kg (change from the baseline, 8.71%). Of the 3161 participants, 2146 had a WL of ≥5%. The best-case subgroup (n = 24; age 36.54 ± 11.64 years) achieved 23.02 ± 4.07 kg WL and reached BMIs < 23 kg/m2 in 7.83 ± 2.54 months; among those with BP indices available (n = 21), reductions were statistically significant. In this subgroup, the mean treatment duration was 8.71 ± 2.46 months (range, 5–15), exceeding the 6-month safety guideline for Ephedrae Herba-containing HM, and no serious AEs were observed. At the 7-month follow-up, 11 patients maintained a statistically significant WL. Conclusions: This is the first Korean study to apply the professional collaboration of IKMT and dietician-led LM to people with obesity. IKMT combined with LM appears to be a safe and effective approach for obesity management. Prospective studies are needed to confirm these findings and establish standardized treatment protocols.
31 December 2024 in Journal of Korean Medicine for Obesity Research
Objective: This study evaluated the effects of herbal medicine combined with a low-carbohydrate diet on weight loss and disease progression in patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD).Methods: A retrospective analysis was conducted on 14 IBD patients (12 UC, 2 CD) who received 60 days of herbal medicine in solid form (pills, tablets, and capsules) and followed a low-carbohydrate diet (50 g/day limit). Body weight and composition were measured before and after treatment, and adverse events were recorded to assess safety.Results: Mean body weight decreased significantly, from 73.00±18.25 kg to 67.98±16.09 kg (p<0.05), with an average weight loss of 6.88%. BMI decreased from 26.84±4.59 kg/m2 to 25.00±4.06 kg/m2. Body fat mass and body fat percentage were significantly reduced, indicating fat loss. Seven patients (50%) reported mild to moderate adverse events, including nausea, indigestion, abdominal pain, sleep disturbances, and headaches. Most patients showed stabilization or improvement in IBD symptoms, such as normalized bowel movements.Conclusion: Herbal medicine combined with a low-carbohydrate diet resulted in significant weight loss and positive effects on IBD symptoms, without serious side effects. Further studies are needed to validate these findings.
30 September 2024 in The Journal of Internal Korean Medicine
This retrospective, multicenter, observational study aimed to evaluate the effects of herbal medicine treatment on liver function in obese patients exhibiting elevated liver enzymes. Conducted from May 2023 to April 2024 at various Korean medicine clinics, the study included 84 patients who underwent herbal treatments for obesity. All participants had at least one liver function test (LFT) showing elevated levels of aspartic amino transferase (AST), alanine amino transferase (ALT), or gamma glutamyl transferase (GGT), and a subsequent LFT performed after a minimum of 90 days. The study excluded patients with potential confounding factors such as hepatitis, antibiotic usage, or recent surgeries.The study showed significant reductions in AST, ALT, and GGT levels, with AST and ALT improving to within the normal range and GGT approaching normal levels. Patients also experienced statistically significant reductions in weight and BMI, meeting the minimum clinically important difference threshold.These findings suggest that herbal treatments for obesity are not only safe for patients with obesity-related liver enzyme abnormalities but also effective in improving liver function. This study shows that herbal treatment is effective in the management of obesity-related liver disease and confirms the safety and efficacy of an obesity treatment herbal formula containing ephedra. Larger prospective studies are needed to confirm these findings.
30 December 2025 in The Journal of Internal Korean Medicine
Objectives: This scoping review aimed to identify recent trends in Traditional Korean Medicine (TKM)-based diabetes research published in Korea.Methods: A structured search was conducted in four major Korean databases (OASIS, KISS, DBpia, RISS) for studies published from 2015 to 2024, using expanded keywords including “diabetes mellitus,” DM, T1DM, and T2DM. Eligible studies were classified into descriptive reviews, experimental studies, clinical studies, case reports, and systematic reviews. Study selection was independently performed by two reviewers.Results: Seventy-four studies were included. Case reports (37.8%) and experimental studies (31.1%) were most common. Experimental studies mainly examined hypoglycemic effects and insulin-related mechanisms. Clinical studies were predominantly retrospective and assessed the effectiveness and safety of herbal medicines alone or in combination with glucose-lowering drugs. Systematic reviews conducted in Korea frequently relied on international randomized controlled trials, highlighting the limited availability of high-quality domestic evidence.Conclusion: Research on TKM-based diabetes has increased; however, prospective clinical trials are needed to strengthen the evidence.
Background and Objectives: Although herbal medicine-based obesity treatment programs are used in obesity management, empirical research on patient acceptability remains limited. This study examined acceptability of a Korean medicine-based obesity treatment program (KM-OBP) among patients who achieved predefined weight-loss targets in routine clinical care. Materials and Methods: Medical records and satisfaction survey data routinely collected during clinical practice at a single Korean medicine clinic were retrospectively analyzed. Patients had baseline body mass index (BMI) ≥ 30 kg/m2 and achieved both ≥10% weight loss and BMI ≤ 23 kg/m2 during follow-up. BMI trajectories and adverse-event occurrence were summarized descriptively. Satisfaction ratings were reported on a 5-point Likert scale, and free-text responses were retrospectively analyzed using the Theoretical Framework of Acceptability. Results: Of 3798 patients with a baseline BMI ≥ 30 kg/m2 and at least two BMI measurements, 37 (0.97%) met the predefined targets; 16 completed the satisfaction survey. Mean BMI change from the first to last measurement was −8.9 kg/m2, and median change was −8.8 kg/m2 (interquartile range, −9.6 to −7.7). Common documented adverse events were constipation, nausea, and dizziness. Satisfaction ratings were descriptively high for the overall program, perceived helpfulness for obesity treatment, and herbal medicine. Among the 16 survey respondents, perceived weight-loss benefits, program structure, safety, and health improvement were described as facilitators of acceptability, whereas post-treatment weight regain, dietary burden, and financial concerns were described as barriers. Conclusions: The findings characterize satisfaction and reported acceptability experiences among survey respondents within a highly selected target-achieving cohort. Interpretation is limited by outcome-based selection, potential non-response bias, the small survey sample, and the single-center design.